Spots Global Cancer Trial Database for haploidentical transplantation
Every month we try and update this database with for haploidentical transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | NCT02646839 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | CliniMacs TCR a... | - 21 Years | Children's Hospital Los Angeles | |
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation | NCT03159702 | Hematological M... Multiple Myelom... | Evomela Fludarabine Total Body Irra... | 18 Years - | Medical College of Wisconsin | |
TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia | NCT04033627 | Relapsed Pediat... Acute Graft-Ver... Relapsed Pediat... | In Vitro T cell... | 2 Months - 18 Years | Shanghai Children's Medical Center | |
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT | NCT05290545 | Hematological M... Hematopoietic S... | PBSCs Cord BMSCs | 18 Years - 65 Years | Nanfang Hospital, Southern Medical University | |
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | NCT02646839 | Acute Lymphobla... Acute Myeloid L... Myelodysplastic... | CliniMacs TCR a... | - 21 Years | Children's Hospital Los Angeles | |
Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). | NCT04687982 | Bone Marrow Tra... Bone Marrow Tra... Graft Vs Host D... Infection Hematological M... | modified donor ... | 18 Years - | Istituto Clinico Humanitas |